PARATEK PHARMACEUTICALS INC's ticker is and the CUSIP is 699374AB0. A total of 19 filers reported holding PARATEK PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $339,000 | -57.3% | 375,000 | -56.3% | 0.00% | 0.0% |
| Q4 2021 | $793,000 | +2.5% | 859,000 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $774,000 | -27.0% | 859,000 | -27.0% | 0.00% | -50.0% |
| Q2 2021 | $1,060,000 | +52.1% | 1,176,000 | +45.0% | 0.00% | +100.0% |
| Q4 2020 | $697,000 | – | 811,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cohanzick Management, LLC | 25,112,000 | $25,557,982 | 22.10% |
| Westchester Capital Management, LLC | 8,267,000 | $8,308,536 | 0.24% |
| MACQUARIE GROUP LTD | 5,359,000 | $5,386,000 | 0.01% |